Randomized trial shows that continuous glucose monitoring improves healthy behaviors in at-risk participants, highlighting its role in prevention.
Cardiovascular diseases are the leading global cause of death. This randomized trial with 48 at-risk participants found that continuous glucose monitoring (CGM) significantly improved healthy lifestyle behaviors. Both groups improved, but the CGM group showed the greatest gains, highlighting CGM's role in promoting awareness and prevention.
No takes yet. Share an insight, caveat, or question.
Svenšek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: